Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With Alectinib
- PMID: 30992232
- DOI: 10.1016/j.clml.2019.03.001
Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With Alectinib
Keywords: Cytogenics; Non-Hodgkin lymphoma; Peripheral T cell lymphoma; Targeted therapy; Treatment toxicity.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
